Convalescent Plasma Therapy in Critically Ill COVID-19 Patients: An Open Label Trial

OBJECTIVES: The novel severe acute respiratory syndrome coronavirus 2 pandemic continues to spread globally without an effective treatment. In search of the cure, convalescent plasma (CP) containing protective antibodies from survivors of coronavirus disease 2019 (COVID-19) infection has shown poten...

Descripción completa

Detalles Bibliográficos
Autores principales: Khamis, Faryal, Al Arimi, Zainab, Al Naamani, Hamed, Al Bahrani, Maher, Pandak, Nenad, Al Bolushi, Zakaryia, Deenadayalan, Stephan S., Al Lawati, Adil, Al Salmi, Issa, Al-Zakwani, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OMJ 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491110/
https://www.ncbi.nlm.nih.gov/pubmed/34631155
http://dx.doi.org/10.5001/omj.2021.105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8491110/
https://www.ncbi.nlm.nih.gov/pubmed/34631155
http://dx.doi.org/10.5001/omj.2021.105

Ejemplares similares